MedPath

Clinical Research on a Novel Deep-learning Based System in Mediastinal Endoscopic Ultrasound Scanning

Not Applicable
Recruiting
Conditions
Mediastinum Disease
Registration Number
NCT05792280
Lead Sponsor
The Third Xiangya Hospital of Central South University
Brief Summary

The goal of this clinical trial is to develop and verify the auxiliary role of the artificial intelligence system in mediastinal ultrasound endoscopic scanning. The main questions it aims to answer are as follows: 1.The comparison of the image recognition accuracy between the artificial intelligence system and the ultrasound endoscopist; 2. Whether the artificial intelligence system can improve the integrity and efficiency of the mediastinum scanning for the ultrasound endoscopist. Participants will undergo mediastinal EUS with or without the assistance of the artificial intelligence system.

Detailed Description

In this study, a total of 200 cases of mediastinal endoscopic ultrasound scanning videos will be collected. First of all, an artificial intelligence system based on deep learning for the navigation and quality control of mediastinal endoscopic ultrasonography will be established. Secondly, the artificial intelligence system will be used to identify the site and anatomical structure of the mediastinal ultrasound endoscope, and the results of the artificial intelligence system's station recognition will be compared with the results of the endoscopist's station recognition. Finally, the completeness of standard sites and scanning time of endoscopic-assisted and non-assisted AI systems were compared.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
180
Inclusion Criteria
    1. Age ≥18 years old, <80 years old 2.Patients who need endoscopic ultrasonography; 3. Agree to participate in this study and sign the informed consent form.
Exclusion Criteria
  • Subjects who meet any of the following criteria cannot be selected for this trial:

First. The patient's physical condition does not meet the requirements of conventional endoscopic ultrasonography:

  1. Poor physical condition, including hemoglobin ≤8.0g/dl, severe cardiopulmonary insufficiency, etc.
  2. Anesthesia assessment failed
  3. Pregnancy or breastfeeding
  4. In the acute stage of chemical and corrosive injury, it is very easy to cause perforation
  5. Recent acute coronary syndrome or clinically unstable ischemic heart attack
  6. Heart disease patients with right-to-left shunt, patients with severe pulmonary hypertension (pulmonary artery pressure> 90mmHg),patients with uncontrolled systemic hypertension and patients with adult respiratory distress syndrome.

Second. Disagree to participate in this study.

Third. There are other problems that do not meet the requirements of this research or that affect the results of the research:

  1. Mediastinal lesions have previously undergone surgery or radiotherapy and chemotherapy;
  2. Mental illness, drug addiction, inability to express themselves or other diseases that may affect follow-up.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The completeness for standard station scanningUntil the end of the study

This was calculated as the number of stations successfully scanned divided by the total number of stations that should have been scanned.

Accuracy1 year

The number of correctly classified images divided by the total number of images.

Secondary Outcome Measures
NameTimeMethod
The incidence of adverse eventsUntil the end of the study

The incidence of adverse events in both groups during the entire research process.

The completeness for standard stations and anatomical landmarks per individualUntil the end of the study

The completeness of stations and anatomic landmarks of endoscopic ultrasonography by different endoscopists in the AI system assisted group and the control group were compared.

The completeness of anatomical landmarksUntil the end of the study

It calculated as the number of anatomical structures successfully scanned divided by the total number of structures that should have been scanned

Operation timeUntil the end of the study

In addition to puncture, elastography, and ultrasound enhancement to observe the lesion or treatment, it can also be used to observe the time of the mediastinum.

Cohen's kappa coefficient1 year

This data is to evaluate the agreement between the model and the endoscopists.

Trial Locations

Locations (1)

The Third Xiangya Hospital of Central South University

🇨🇳

Changsha, Hunan, China

The Third Xiangya Hospital of Central South University
🇨🇳Changsha, Hunan, China
Xiaoyan Wang, Doctor
Contact
+8613974889301
wxy20011@163.com
Shiqin Huang, Doctor
Contact
+8618308312098
sqhuang0213@163.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.